A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)

NCT02363946 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

65

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision to terminate the trial

Conditions

Alpha-1 Antitrypsin Deficiency

Interventions

DRUG: ARC-AAT Injection
OTHER: Placebo
DRUG: Diphenhydramine

Sponsor

Arrowhead Pharmaceuticals